Michael Roden

A multisociety Delphi consensus statement on new fatty liver disease nomenclature

Mary E. Rinella, Jeffrey V. Lazarus, Vlad Ratziu et al. · Hepatology · 2023 · 2.5K citations · Full text

Evidence-based Medicine, Pathology, Fatty Liver Disease +16

Systematic identification of trans eQTLs as putative drivers of known disease associations

Harm-Jan Westra, Marjolein J. Peters, Tōnu Esko et al. · Nature Genetics · 2013 · 1.7K citations · Full text

Systematic Identification, Autoimmune Disease, Allergy +11

Mechanism of free fatty acid-induced insulin resistance in humans.

Michael Roden, Thomas B. Price, Gianluca Perseghin et al. · Journal of Clinical Investigation · 1996 · 1.5K citations · Full text

Healthy Subjects, Insulin Signaling, Metabolic Syndrome +16

Intramyocellular lipid concentrations are correlated with insulin sensitivity in humans: a 1 H NMR spectroscopy study

Martin Krššák, Kitt Falk Petersen, Alan Dresner et al. · Diabetologia · 1999 · 1.3K citations · Full text

Obesity, Metabolic Syndrome, Insulin Sensitivity +12

EASL–EASD–EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD)

Frank Tacke, Paul Horn, Vincent Wai‐Sun Wong et al. · Journal of Hepatology · 2024 · 1.2K citations · Full text

Obesity, Metabolic Syndrome, Metabolic Associated Steatohepatitis +14